Stereotaxis

STXSNYSE United States Health Care Biotechnology: Electromedical & Electrotherapeutic Apparatus

Market cap

$140.283 M

$1.40 +2.94%

Close of 22 Sept 2026

Revenue

$32.4M

#2860 by revenue

Earnings

-$21.6M

Loss-making

Shares outstanding

100,202,178

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Electromedical & Electrotherapeutic Apparatus, ranked by market cap

All 28 →

#12SolanaHSDT$197.7M
#13Edap TmsFOCL$160.2M
#14StereotaxisSTXS$140.3M
#15Vivani MedicalVANI$114.6M
#16electroCoreECOR$110.8M

What if Stereotaxis were worth as much as…

Open the what-if tool →

Gold $30.2T

$301,729.67

Per share 215,521× higher

Bitcoin $1.74T

$17,381.41

Per share 12,415× higher

Nvidia $5.52T

$55,046.38

Per share 39,319× higher

Or at a round number

$200.0M $500.0M $1.00B $2.00B

Where these numbers come from

Share counts and financials for Stereotaxis are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.